More Press Releases

View Older Stories View Newer Stories

Dec 7, 2025 10:39AM Elysium Wealth Advisors Announces Expert Financial Services for Expatriates
Dec 7, 2025 10:26AM Azerbaijan has launched it’s first-ever student satellite
Dec 7, 2025 10:11AM PEARL HARBOR AVIATION MUSEUM LAUNCHES $51 MILLION "REMEMBER PEARL HARBOR" NATIONAL CAMPAIGN ON DECEMBER 7th TO RESTORE AMERICA'S WORLD WAR II AVIATION BATTLEFIELD
Dec 7, 2025 10:08AM New Era Releases 2025 Major League Soccer Champions Collection Celebrating Inter Miami CF
Dec 7, 2025 09:48AM The 4th China International Supply Chain Expo Set for Beijing in June 2026
Dec 7, 2025 09:30AM Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
Dec 7, 2025 09:30AM Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
Dec 7, 2025 09:30AM Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
Dec 7, 2025 09:30AM Nayax Considering an Offering of Notes and Warrants in Israel
Dec 7, 2025 09:00AM SOUTH32 Hermosa Mine Discharge Shows Antimony Above State Alert Level and Near Regulatory Limit, Raising Concerns About Water Quality Trends
Dec 7, 2025 08:07AM Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation
Dec 7, 2025 08:05AM Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
Dec 7, 2025 08:00AM CellCentric Presents Positive Phase 2 Dose Optimization Data for Inobrodib in Multiple Myeloma at ASH Annual Meeting
Dec 7, 2025 08:01AM Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting
Dec 7, 2025 08:00AM Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
Dec 7, 2025 08:00AM Orna Therapeutics Presents New Data Supporting its in vivo CAR Programs for Autoimmune Diseases and Oncology at the 67th American Society of Hematology Annual Meeting
Dec 7, 2025 08:00AM Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review
Dec 7, 2025 08:00AM ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodg
Dec 7, 2025 07:54AM Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation
Dec 7, 2025 07:50AM Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R²) in Patients with Relap
Dec 7, 2025 07:50AM Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relaps
Dec 7, 2025 07:49AM How Roofing Expert Tom Meadows of Ann Arbor Explains Roof Repair vs. Roof Replacement for HelloNation
Dec 7, 2025 10:24AM This Holiday Season, Let’s Lower the Temperature By Jagdish Khubchandani and Marc Ransford
Dec 7, 2025 07:30AM Studies Point to a Growing Role for New Therapies and Immunotherapies in Treating Blood Cancers
Dec 7, 2025 07:00AM CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future
Dec 7, 2025 07:00AM Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
Dec 7, 2025 07:00AM Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science
Dec 7, 2025 06:57AM Payre: Solving Late Payments Woes by Making Legal Debt Recovery Platform Accessible to All
Dec 7, 2025 06:57AM EnglishSparklingWines.com Releases Updated Analysis: Highlights Growing Attention Toward English Sparkling Wine
Dec 7, 2025 08:52AM Kravdin: This AI coin goes big, how to get bonus
Dec 7, 2025 06:00AM HALLMARK PRESENTS A DISNEY LOVE STORY
Dec 7, 2025 06:00AM New Crypto Mutuum Finance Completes Phase 1 Roadmap Milestones, Builds Momentum Into Phase 2
Dec 7, 2025 05:40AM BLU3 and 4ocean Join Forces for Ocean Conservation
Dec 7, 2025 05:30AM Washable Area Rugs (2025): Rugs Direct Named Top Choice for Practical & Stylish Home Decor by Expert Consumers
Dec 7, 2025 05:00AM Best Accounting Software for Self-Employed (2025): QuickBooks Named Top Choice for Freelancers and Entrepreneurs by Expert Consumers
Dec 7, 2025 04:22AM WelcomeVille Investment Association Led by Reginald Pembroke Releases the Learning Innovation Outlook Report
Dec 7, 2025 04:21AM CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
Dec 7, 2025 04:09AM 2025 "Silk Road for All Children" International Children's Literature Week The 10th Fairy Tales Conference Held in Wuyi, China
Dec 7, 2025 04:00AM Funding Reaches $19.2M as Mutuum Finance (MUTM) Presale Moves Toward Full Allocation
Dec 7, 2025 03:45AM Laser Center of Marin Highlights Versatile Benefits of Botox in Corte Madera, CA
Dec 7, 2025 03:40AM Injectable Treatment at Esthetics Center: Discover & Enhance Your Confidence
Dec 7, 2025 03:40AM Smooth Confidence: Laser Hair Removal at Anne Therese Aesthetic Medicine
Dec 7, 2025 03:25AM Top Pressure Washing Services Available in Clermont, Florida
Dec 7, 2025 03:25AM Revolutionizing SEO with AI Technology
Dec 7, 2025 03:25AM New Healthcare Construction Division to Enhance HVAC Services
Dec 7, 2025 03:00AM Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Dec 7, 2025 02:50AM i-TECH e-Services: Your Trusted Partner for PCB Assembly and More
Dec 7, 2025 02:35AM Reliable Commercial Wiring Services in Cypress, CA
Dec 7, 2025 01:18AM All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
Dec 7, 2025 12:11AM Zai Lab Announces Updates to China’s National Reimbursement Drug List
View Newer Stories View Older Stories